Dexcom G6 has been approved by the FDA. Most exciting new features setting it apart from the G5 include: no calibrations, approval for 10-day wear, and a new one-touch auto-applicator as well as a slimmer profile. The G6 is the first CGM designed to be used with other compatible medical devices, opening the door for exciting integrations in future insulin pump closed-loop systems. It is approved for patients 2 years and older. Dexcom has indicated that it will begin shipping to patients soon - contact your Dexcom representative for specifics.
Beyond Type 1 will continue with additional coverage as more information becomes available.